Review





Similar Products

96
Broad Clinical Labs single cell rna sequencing dataset scp259
Single Cell Rna Sequencing Dataset Scp259, supplied by Broad Clinical Labs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/single cell rna sequencing dataset scp259/product/Broad Clinical Labs
Average 96 stars, based on 1 article reviews
single cell rna sequencing dataset scp259 - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier

86
Biogen Inc dataset chembl
Visualization of chemical space diversity using a t-SNE plot of RDKit molecular descriptors for Biogen (green), <t>ChEMBL</t> (teal), NCATS (purple), AstraZeneca (orange), Polaris (magenta). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Dataset Chembl, supplied by Biogen Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dataset chembl/product/Biogen Inc
Average 86 stars, based on 1 article reviews
dataset chembl - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Biogen Inc adme dataset
Visualization of chemical space diversity using a t-SNE plot of RDKit molecular descriptors for Biogen (green), <t>ChEMBL</t> (teal), NCATS (purple), AstraZeneca (orange), Polaris (magenta). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Adme Dataset, supplied by Biogen Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/adme dataset/product/Biogen Inc
Average 86 stars, based on 1 article reviews
adme dataset - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Biogen Inc dataset biogen model
Visualization of chemical space diversity using a t-SNE plot of RDKit molecular descriptors for Biogen (green), <t>ChEMBL</t> (teal), NCATS (purple), AstraZeneca (orange), Polaris (magenta). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Dataset Biogen Model, supplied by Biogen Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dataset biogen model/product/Biogen Inc
Average 86 stars, based on 1 article reviews
dataset biogen model - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
10X Genomics cell transcriptomic sequencing dataset
<t>Transcriptomic</t> and TME characteristics associated with ECMSig in TCGA-GBM cohort (A) Volcano plot showing DEGs between ECMSig-high and ECMSig-low groups. Red dots: upregulated in high-risk; blue dots: upregulated in low-risk. Benjamini-Hochberg adjusted. (B) Gene set enrichment analysis (GSEA) plots showing enrichment of hallmark pathways. Pathways enriched in ECMSig-high and ECMSig-low groups are shown with their running enrichment scores (ESs) and ranked gene lists. Benjamini-Hochberg adjusted. (C) Heatmap showing the activity scores of selected oncogenic and tumor-related signaling pathways (rows) across TCGA-GBM samples (columns), annotated by ECMSig group and ECMSig score. Red indicates high activity, blue indicates low activity. ∗ p < 0.05. Wilcoxon signed-rank test. (D) Heatmap depicting the estimated infiltration levels of various immune and stromal cell types (rows) in TCGA-GBM samples (columns), stratified by ECMSig group and score. Red indicates high infiltration, blue indicates low infiltration. Cells significantly highly infiltrated in ECMSig-high are labeled in red, and those high in ECMSig-low group are in blue. ∗q < 0.05, ∗∗q < 0.01, ∗∗∗q < 0.001. Wilcoxon signed-rank test. Benjamini-Hochberg adjusted. (E and F) Scatterplots showing the spearman correlation between ECMSig score and (E) Macrophage_XCELL infiltration score and (F) immune_score_XCELL. The blue line represents the linear regression fit with 95% confidence interval bands. Spearman correlation test.
Cell Transcriptomic Sequencing Dataset, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cell transcriptomic sequencing dataset/product/10X Genomics
Average 86 stars, based on 1 article reviews
cell transcriptomic sequencing dataset - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Human Protein Atlas transcriptome datasets
Overview of TiSMeD TiSMeD is a comprehensive resource that integrates 6,782 methylomes, 16,894 <t>transcriptomes,</t> and 241 proteomes obtained from multiple platforms. All datasets were processed using a standardized pipeline, resulting in the identification of 67,427 TSMs, 4,607 TSGs, and 2,833 TSPs based on tissue specificity and confidence score evaluation. In addition, TiSMeD includes 11,411,136 HKMs. TiSMeD features a user-friendly interface that enables data searching, browsing, downloading, and visualization.
Transcriptome Datasets, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/transcriptome datasets/product/Human Protein Atlas
Average 86 stars, based on 1 article reviews
transcriptome datasets - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Kaggle Inc flower recognition dataset
Overview of TiSMeD TiSMeD is a comprehensive resource that integrates 6,782 methylomes, 16,894 <t>transcriptomes,</t> and 241 proteomes obtained from multiple platforms. All datasets were processed using a standardized pipeline, resulting in the identification of 67,427 TSMs, 4,607 TSGs, and 2,833 TSPs based on tissue specificity and confidence score evaluation. In addition, TiSMeD includes 11,411,136 HKMs. TiSMeD features a user-friendly interface that enables data searching, browsing, downloading, and visualization.
Flower Recognition Dataset, supplied by Kaggle Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/flower recognition dataset/product/Kaggle Inc
Average 86 stars, based on 1 article reviews
flower recognition dataset - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Mendeley Ltd mendeley data dataset
Overview of TiSMeD TiSMeD is a comprehensive resource that integrates 6,782 methylomes, 16,894 <t>transcriptomes,</t> and 241 proteomes obtained from multiple platforms. All datasets were processed using a standardized pipeline, resulting in the identification of 67,427 TSMs, 4,607 TSGs, and 2,833 TSPs based on tissue specificity and confidence score evaluation. In addition, TiSMeD includes 11,411,136 HKMs. TiSMeD features a user-friendly interface that enables data searching, browsing, downloading, and visualization.
Mendeley Data Dataset, supplied by Mendeley Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mendeley data dataset/product/Mendeley Ltd
Average 86 stars, based on 1 article reviews
mendeley data dataset - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Boston Scientific Corporation madit ii datasets
Estimated ICERs and 95% CIs for the MADIT-CRT <t>and</t> <t>MADIT-II</t> trials. The dots represent 1000 bootstrap samples. The solid lines denote the estimated ICERs; the black dashed lines and the gray dot-dashed lines indicate CI limits obtained by the IMP method and the bootstrap method, respectively. Panels (A) and (B) present results using HF-free QAL as the effectiveness measure for the LBBB and non-LBBB subgroups in the MADIT-CRT study (4-year time horizon). Panel (C) presents results using YOL as the effectiveness measure in the MADIT-II study (3.5-year time horizon).
Madit Ii Datasets, supplied by Boston Scientific Corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/madit ii datasets/product/Boston Scientific Corporation
Average 86 stars, based on 1 article reviews
madit ii datasets - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Kaggle Inc nsl kdd dataset
Estimated ICERs and 95% CIs for the MADIT-CRT <t>and</t> <t>MADIT-II</t> trials. The dots represent 1000 bootstrap samples. The solid lines denote the estimated ICERs; the black dashed lines and the gray dot-dashed lines indicate CI limits obtained by the IMP method and the bootstrap method, respectively. Panels (A) and (B) present results using HF-free QAL as the effectiveness measure for the LBBB and non-LBBB subgroups in the MADIT-CRT study (4-year time horizon). Panel (C) presents results using YOL as the effectiveness measure in the MADIT-II study (3.5-year time horizon).
Nsl Kdd Dataset, supplied by Kaggle Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nsl kdd dataset/product/Kaggle Inc
Average 86 stars, based on 1 article reviews
nsl kdd dataset - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

Image Search Results


Visualization of chemical space diversity using a t-SNE plot of RDKit molecular descriptors for Biogen (green), ChEMBL (teal), NCATS (purple), AstraZeneca (orange), Polaris (magenta). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

Journal: Results in chemistry

Article Title: Assessing the impact of data harmonization on human liver microsomal stability prediction model performance

doi: 10.1016/j.rechem.2026.103305

Figure Lengend Snippet: Visualization of chemical space diversity using a t-SNE plot of RDKit molecular descriptors for Biogen (green), ChEMBL (teal), NCATS (purple), AstraZeneca (orange), Polaris (magenta). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

Article Snippet: The single-dataset ChEMBL and single-dataset NCATS models showed comparable performance to each other across all metrics and both the single-dataset ChEMBL and single-dataset NCATS models generally improved with the addition of Biogen data.

Techniques:

Transcriptomic and TME characteristics associated with ECMSig in TCGA-GBM cohort (A) Volcano plot showing DEGs between ECMSig-high and ECMSig-low groups. Red dots: upregulated in high-risk; blue dots: upregulated in low-risk. Benjamini-Hochberg adjusted. (B) Gene set enrichment analysis (GSEA) plots showing enrichment of hallmark pathways. Pathways enriched in ECMSig-high and ECMSig-low groups are shown with their running enrichment scores (ESs) and ranked gene lists. Benjamini-Hochberg adjusted. (C) Heatmap showing the activity scores of selected oncogenic and tumor-related signaling pathways (rows) across TCGA-GBM samples (columns), annotated by ECMSig group and ECMSig score. Red indicates high activity, blue indicates low activity. ∗ p < 0.05. Wilcoxon signed-rank test. (D) Heatmap depicting the estimated infiltration levels of various immune and stromal cell types (rows) in TCGA-GBM samples (columns), stratified by ECMSig group and score. Red indicates high infiltration, blue indicates low infiltration. Cells significantly highly infiltrated in ECMSig-high are labeled in red, and those high in ECMSig-low group are in blue. ∗q < 0.05, ∗∗q < 0.01, ∗∗∗q < 0.001. Wilcoxon signed-rank test. Benjamini-Hochberg adjusted. (E and F) Scatterplots showing the spearman correlation between ECMSig score and (E) Macrophage_XCELL infiltration score and (F) immune_score_XCELL. The blue line represents the linear regression fit with 95% confidence interval bands. Spearman correlation test.

Journal: iScience

Article Title: Multi-omics profiling-derived signature links cellular ecosystem to glioblastoma prognosis

doi: 10.1016/j.isci.2026.115982

Figure Lengend Snippet: Transcriptomic and TME characteristics associated with ECMSig in TCGA-GBM cohort (A) Volcano plot showing DEGs between ECMSig-high and ECMSig-low groups. Red dots: upregulated in high-risk; blue dots: upregulated in low-risk. Benjamini-Hochberg adjusted. (B) Gene set enrichment analysis (GSEA) plots showing enrichment of hallmark pathways. Pathways enriched in ECMSig-high and ECMSig-low groups are shown with their running enrichment scores (ESs) and ranked gene lists. Benjamini-Hochberg adjusted. (C) Heatmap showing the activity scores of selected oncogenic and tumor-related signaling pathways (rows) across TCGA-GBM samples (columns), annotated by ECMSig group and ECMSig score. Red indicates high activity, blue indicates low activity. ∗ p < 0.05. Wilcoxon signed-rank test. (D) Heatmap depicting the estimated infiltration levels of various immune and stromal cell types (rows) in TCGA-GBM samples (columns), stratified by ECMSig group and score. Red indicates high infiltration, blue indicates low infiltration. Cells significantly highly infiltrated in ECMSig-high are labeled in red, and those high in ECMSig-low group are in blue. ∗q < 0.05, ∗∗q < 0.01, ∗∗∗q < 0.001. Wilcoxon signed-rank test. Benjamini-Hochberg adjusted. (E and F) Scatterplots showing the spearman correlation between ECMSig score and (E) Macrophage_XCELL infiltration score and (F) immune_score_XCELL. The blue line represents the linear regression fit with 95% confidence interval bands. Spearman correlation test.

Article Snippet: The single-cell transcriptomic sequencing dataset utilizing technology from the 10X Genomics platform was available under the accession number GEO: GSE182109 at the Gene Expression Omnibus (GEO) repository.

Techniques: Activity Assay, Protein-Protein interactions, Labeling

Single-cell RNA sequencing analysis revealing ECMSig expression across cell types and identification of prognostically relevant cell states in GBM (A) UMAP visualization of major cell types identified in GBM scRNA-seq data. (B) Dot plot showing the scaled average expression (color intensity) and percentage of cells expressing (dot size) canonical marker genes for each major cell type. (C) Dot plot showing the scaled average expression and percentage of cells expressing the seven ECMSig genes across major cell types. (D) UMAP plots showing the expression levels of individual ECMSig genes and overall ECMSig score across all cells. (E–G) UMAP plots illustrating Scissor-identified prognostically unfavorable (Scissor_Pos, red dashed circle) and favorable (Scissor_Neg, blue dashed circle; Scissor_Others, gray) cell subpopulations within (E) tumor cells, (F) myeloid cells, and (G) endothelial cells. (H–K) Violin plots comparing ECMSig scores among tumor cells grouped by Scissor status (H) and tumor type (I), and myeloid cells (J) or endothelial cells (K) grouped by Scissor status. ∗∗∗∗ p < 0.0001. Wilcoxon signed-rank test. (L) Dot plot showing differentially expressed marker genes between myeloid Scissor_Pos and other myeloid cells. Dot size indicates the fraction of cells in the group expressing the gene; color indicates average expression level.

Journal: iScience

Article Title: Multi-omics profiling-derived signature links cellular ecosystem to glioblastoma prognosis

doi: 10.1016/j.isci.2026.115982

Figure Lengend Snippet: Single-cell RNA sequencing analysis revealing ECMSig expression across cell types and identification of prognostically relevant cell states in GBM (A) UMAP visualization of major cell types identified in GBM scRNA-seq data. (B) Dot plot showing the scaled average expression (color intensity) and percentage of cells expressing (dot size) canonical marker genes for each major cell type. (C) Dot plot showing the scaled average expression and percentage of cells expressing the seven ECMSig genes across major cell types. (D) UMAP plots showing the expression levels of individual ECMSig genes and overall ECMSig score across all cells. (E–G) UMAP plots illustrating Scissor-identified prognostically unfavorable (Scissor_Pos, red dashed circle) and favorable (Scissor_Neg, blue dashed circle; Scissor_Others, gray) cell subpopulations within (E) tumor cells, (F) myeloid cells, and (G) endothelial cells. (H–K) Violin plots comparing ECMSig scores among tumor cells grouped by Scissor status (H) and tumor type (I), and myeloid cells (J) or endothelial cells (K) grouped by Scissor status. ∗∗∗∗ p < 0.0001. Wilcoxon signed-rank test. (L) Dot plot showing differentially expressed marker genes between myeloid Scissor_Pos and other myeloid cells. Dot size indicates the fraction of cells in the group expressing the gene; color indicates average expression level.

Article Snippet: The single-cell transcriptomic sequencing dataset utilizing technology from the 10X Genomics platform was available under the accession number GEO: GSE182109 at the Gene Expression Omnibus (GEO) repository.

Techniques: Single Cell, RNA Sequencing, Expressing, Marker

Spatial transcriptomic analysis revealing co-localization of ECMSig, hypoxia, Scissor-Positive cells, and pericytes in GBM (A) Spatial feature plots for four GBM samples. Each row represents a sample. Columns show spatial heatmaps of: ECMSig score, hypoxia signature score, tumor Scissor_Pos signature score, myeloid Scissor_Pos signature score, endothelial Scissor Pos signature score, and pericyte marker signature score. Color scale indicates scaled expression or score (low to high). Each dot represents a spatial barcoded spot.

Journal: iScience

Article Title: Multi-omics profiling-derived signature links cellular ecosystem to glioblastoma prognosis

doi: 10.1016/j.isci.2026.115982

Figure Lengend Snippet: Spatial transcriptomic analysis revealing co-localization of ECMSig, hypoxia, Scissor-Positive cells, and pericytes in GBM (A) Spatial feature plots for four GBM samples. Each row represents a sample. Columns show spatial heatmaps of: ECMSig score, hypoxia signature score, tumor Scissor_Pos signature score, myeloid Scissor_Pos signature score, endothelial Scissor Pos signature score, and pericyte marker signature score. Color scale indicates scaled expression or score (low to high). Each dot represents a spatial barcoded spot.

Article Snippet: The single-cell transcriptomic sequencing dataset utilizing technology from the 10X Genomics platform was available under the accession number GEO: GSE182109 at the Gene Expression Omnibus (GEO) repository.

Techniques: Marker, Expressing

Overview of TiSMeD TiSMeD is a comprehensive resource that integrates 6,782 methylomes, 16,894 transcriptomes, and 241 proteomes obtained from multiple platforms. All datasets were processed using a standardized pipeline, resulting in the identification of 67,427 TSMs, 4,607 TSGs, and 2,833 TSPs based on tissue specificity and confidence score evaluation. In addition, TiSMeD includes 11,411,136 HKMs. TiSMeD features a user-friendly interface that enables data searching, browsing, downloading, and visualization.

Journal: Molecular Therapy. Nucleic Acids

Article Title: TiSMeD: A tissue-specific methylation and expression database for biomarker and translational applications

doi: 10.1016/j.omtn.2026.102884

Figure Lengend Snippet: Overview of TiSMeD TiSMeD is a comprehensive resource that integrates 6,782 methylomes, 16,894 transcriptomes, and 241 proteomes obtained from multiple platforms. All datasets were processed using a standardized pipeline, resulting in the identification of 67,427 TSMs, 4,607 TSGs, and 2,833 TSPs based on tissue specificity and confidence score evaluation. In addition, TiSMeD includes 11,411,136 HKMs. TiSMeD features a user-friendly interface that enables data searching, browsing, downloading, and visualization.

Article Snippet: The transcriptome datasets were obtained from GEO, , the Genotype-Tissue Expression (GTEx) database, the Human Protein Atlas (HPA), and the RNA-seq Atlas.

Techniques:

Estimated ICERs and 95% CIs for the MADIT-CRT and MADIT-II trials. The dots represent 1000 bootstrap samples. The solid lines denote the estimated ICERs; the black dashed lines and the gray dot-dashed lines indicate CI limits obtained by the IMP method and the bootstrap method, respectively. Panels (A) and (B) present results using HF-free QAL as the effectiveness measure for the LBBB and non-LBBB subgroups in the MADIT-CRT study (4-year time horizon). Panel (C) presents results using YOL as the effectiveness measure in the MADIT-II study (3.5-year time horizon).

Journal: Biometrics

Article Title: Regression methods for cost-effectiveness analysis with different censoring times or terminating events for survival time and costs

doi: 10.1093/biomtc/ujag073

Figure Lengend Snippet: Estimated ICERs and 95% CIs for the MADIT-CRT and MADIT-II trials. The dots represent 1000 bootstrap samples. The solid lines denote the estimated ICERs; the black dashed lines and the gray dot-dashed lines indicate CI limits obtained by the IMP method and the bootstrap method, respectively. Panels (A) and (B) present results using HF-free QAL as the effectiveness measure for the LBBB and non-LBBB subgroups in the MADIT-CRT study (4-year time horizon). Panel (C) presents results using YOL as the effectiveness measure in the MADIT-II study (3.5-year time horizon).

Article Snippet: While the data transfer and use agreements prohibit making the MADIT-CRT and MADIT-II datasets publicly available, Boston Scientific may share the data with qualified researchers, available at https://www.bostonscientific.com/en-US/data-sharing-requests.html

Techniques: